ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers-Does One Size Fit All?

被引:0
|
作者
Rhodin, Kristen E. [1 ]
Lidsky, Michael E. [1 ]
机构
[1] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27708 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1245/s10434-023-13584-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4822 / 4823
页数:2
相关论文
共 50 条
  • [21] Chemotherapy dosing in older adults with cancer: One size does NOT fit all
    Williams, Grant R.
    Outlaw, Darryl
    Harvey, R. Donald
    Lichtman, Stuart M.
    Zamboni, William C.
    Giri, Smith
    JOURNAL OF GERIATRIC ONCOLOGY, 2023, 14 (01)
  • [22] Evaluation of Biliary Bacterial Resistance in Patients with Frequent Biliary Instrumentation, One Size Does Not Fit All
    Masadeh, Maen
    Chandra, Subhash
    Livorsi, Daniel
    Johlin, Frederick
    Silverman, William
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (12) : 3474 - 3479
  • [23] Evaluation of Biliary Bacterial Resistance in Patients with Frequent Biliary Instrumentation, One Size Does Not Fit All
    Maen Masadeh
    Subhash Chandra
    Daniel Livorsi
    Frederick Johlin
    William Silverman
    Digestive Diseases and Sciences, 2018, 63 : 3474 - 3479
  • [24] Evaluation of Biliary Bacterial Resistance in Patients With Frequent Biliary Instrumentation: One Size Does Not Fit All
    Masadeh, Maen
    Chandra, Subhash
    Johlin, Frederick
    Livorsi, Daniel
    Silverman, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S36 - S37
  • [25] Biodegradable stents in the treatment of benign biliary strictures: Does one size fit all?
    Koksal, Aydin Seref
    Eminler, Ahmet T.
    Parlak, Erkan
    DIGESTIVE ENDOSCOPY, 2017, 29 (06) : 731 - 732
  • [26] ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis
    Kubo, Masahiko
    Kobayashi, Shogo
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (02) : 945 - 946
  • [27] ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis
    Masahiko Kubo
    Shogo Kobayashi
    Annals of Surgical Oncology, 2022, 29 : 945 - 946
  • [28] ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients
    Olecki, Elizabeth J.
    Gusani, Niraj J.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3123 - 3123
  • [29] ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients
    Elizabeth J. Olecki
    Niraj J. Gusani
    Annals of Surgical Oncology, 2021, 28 : 3123 - 3123
  • [30] ASO Author Reflections: Phase II Trial of Adjuvant Chemotherapy with S-1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
    Tomoki Ebata
    Takashi Mizuno
    Annals of Surgical Oncology, 2020, 27 : 2357 - 2358